showed a trendP = 0.052
At 12 months, patients showed a trend towards the highest efficacy in the 75% advancement group compared with the 60% and 90% groups ( H , 5.928; P = 0.052).
At 12 months, patients showed a trend towards the highest efficacy in the 75% advancement group compared with the 60% and 90% groups ( H , 5.928; P = 0.052).
When the protrusion level was evaluated after 3 months, the largest decrease in AHI and ODI was seen in patients set at an advancement level of 75%, which tended towards significance ( H , 3.778; P = 0.052).